APO Research

APO RESEARCH · REPORT

Anti-Mullerian Hormone (AMH) Test

Selected research

Market Structure

Global Anti-Mullerian Hormone (AMH) Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Anti-Mullerian Hormone (AMH) Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-Mullerian Hormone (AMH) Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Mullerian Hormone (AMH) Test include Roche, Beckman Coulter, BioMérieux, Monash IVF, Bumrungrad International Hospital, CTK Biotech, Biotime, Boditech Med and CREATE Fertility, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Anti-Mullerian Hormone (AMH) Test market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Mullerian Hormone (AMH) Test and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Mullerian Hormone (AMH) Test revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Anti-Mullerian Hormone (AMH) Test market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Mullerian Hormone (AMH) Test Segment by Company

Roche

Beckman Coulter

BioMérieux

Monash IVF

Bumrungrad International Hospital

CTK Biotech

Biotime

Boditech Med

CREATE Fertility

Repromed Fertility Specialists

Quest Health

Clinpath Pathology

Shenzhen YHLO Biotech

Guangzhou Kangrun Biotechnology

Guangzhou Wondfo Biotech

Beijing Savant Biotechnology

Anti-Mullerian Hormone (AMH) Test Segment by Type

Chemiluminescence Immunoassay

ELISA

Magnetic Particle Chemiluminescence

Flow Cytometry Fluorescence Luminescence

Other

Anti-Mullerian Hormone (AMH) Test Segment by Application

Assisted Reproduction

Polycystic Ovary Syndrome

Ovarian Cancer

Other

Anti-Mullerian Hormone (AMH) Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Mullerian Hormone (AMH) Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Mullerian Hormone (AMH) Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Mullerian Hormone (AMH) Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Anti-Mullerian Hormone (AMH) Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Mullerian Hormone (AMH) Test industry.

Chapter 3: Detailed analysis of Anti-Mullerian Hormone (AMH) Test companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Mullerian Hormone (AMH) Testrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Chemiluminescence Immunoassay Table 3. Key Players of ELISA Table 4. Key Players of Magnetic Particle Chemiluminescence Table 3. Key Players of Flow Cytometry Fluorescence Luminescence Table 4. Key Players of Other Table 5. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Assisted Reproduction Table 7. Key Players of Polycystic Ovary Syndrome Table 8. Key Players of Ovarian Cancer Table 9. Key Players of Other Table 10. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region (2021-2026) Table 13. Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region (2027-2032) Table 15. Anti-Mullerian Hormone (AMH) Test Industry Trends Table 16. Anti-Mullerian Hormone (AMH) Test Industry Drivers Table 17. Anti-Mullerian Hormone (AMH) Test Industry Opportunities and Challenges Table 18. Anti-Mullerian Hormone (AMH) Test Industry Restraints Table 19. Global Anti-Mullerian Hormone (AMH) Test Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Company (2021-2026) Table 21. Global Anti-Mullerian Hormone (AMH) Test Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Anti-Mullerian Hormone (AMH) Test Key Company Head Office and Area Served Table 23. Global Anti-Mullerian Hormone (AMH) Test Company, Product Type & Application Table 24. Global Anti-Mullerian Hormone (AMH) Test Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Anti-Mullerian Hormone (AMH) Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Anti-Mullerian Hormone (AMH) Test Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Type (2021-2026) Table 31. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Type (2027-2032) Table 32. Global Anti-Mullerian Hormone (AMH) Test Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Application (2021-2026) Table 36. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Application (2027-2032) Table 37. Roche Company Information Table 38. Roche Business Overview Table 39. Roche Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Roche Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 41. Roche Recent Development Table 42. Beckman Coulter Company Information Table 43. Beckman Coulter Business Overview Table 44. Beckman Coulter Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Beckman Coulter Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 46. Beckman Coulter Recent Development Table 47. BioMérieux Company Information Table 48. BioMérieux Business Overview Table 49. BioMérieux Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. BioMérieux Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 51. BioMérieux Recent Development Table 52. Monash IVF Company Information Table 53. Monash IVF Business Overview Table 54. Monash IVF Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Monash IVF Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 56. Monash IVF Recent Development Table 57. Bumrungrad International Hospital Company Information Table 58. Bumrungrad International Hospital Business Overview Table 59. Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 61. Bumrungrad International Hospital Recent Development Table 62. CTK Biotech Company Information Table 63. CTK Biotech Business Overview Table 64. CTK Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. CTK Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 66. CTK Biotech Recent Development Table 67. Biotime Company Information Table 68. Biotime Business Overview Table 69. Biotime Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Biotime Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 71. Biotime Recent Development Table 72. Boditech Med Company Information Table 73. Boditech Med Business Overview Table 74. Boditech Med Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Boditech Med Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 76. Boditech Med Recent Development Table 77. CREATE Fertility Company Information Table 78. CREATE Fertility Business Overview Table 79. CREATE Fertility Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. CREATE Fertility Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 81. CREATE Fertility Recent Development Table 82. Repromed Fertility Specialists Company Information Table 83. Repromed Fertility Specialists Business Overview Table 84. Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 86. Repromed Fertility Specialists Recent Development Table 87. Quest Health Company Information Table 88. Quest Health Business Overview Table 89. Quest Health Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Quest Health Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 91. Quest Health Recent Development Table 92. Clinpath Pathology Company Information Table 93. Clinpath Pathology Business Overview Table 94. Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 96. Clinpath Pathology Recent Development Table 97. Shenzhen YHLO Biotech Company Information Table 98. Shenzhen YHLO Biotech Business Overview Table 99. Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 101. Shenzhen YHLO Biotech Recent Development Table 102. Guangzhou Kangrun Biotechnology Company Information Table 103. Guangzhou Kangrun Biotechnology Business Overview Table 104. Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 106. Guangzhou Kangrun Biotechnology Recent Development Table 107. Guangzhou Wondfo Biotech Company Information Table 108. Guangzhou Wondfo Biotech Business Overview Table 109. Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 111. Guangzhou Wondfo Biotech Recent Development Table 112. Beijing Savant Biotechnology Company Information Table 113. Beijing Savant Biotechnology Business Overview Table 114. Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 116. Beijing Savant Biotechnology Recent Development Table 117. North America Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026) & (US$ Million) Table 118. North America Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032) & (US$ Million) Table 119. North America Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026) & (US$ Million) Table 120. North America Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032) & (US$ Million) Table 121. North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026) Table 123. North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032) Table 124. Europe Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026) & (US$ Million) Table 125. Europe Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032) & (US$ Million) Table 126. Europe Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026) & (US$ Million) Table 127. Europe Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032) & (US$ Million) Table 128. Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026) Table 130. Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032) Table 131. China Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026) & (US$ Million) Table 132. China Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032) & (US$ Million) Table 133. China Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026) & (US$ Million) Table 134. China Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032) & (US$ Million) Table 135. Asia Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026) & (US$ Million) Table 136. Asia Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032) & (US$ Million) Table 137. Asia Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026) & (US$ Million) Table 138. Asia Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032) & (US$ Million) Table 139. Asia Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026) Table 141. Asia Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032) Table 142. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026) & (US$ Million) Table 145. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032) & (US$ Million) Table 146. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026) Table 148. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Anti-Mullerian Hormone (AMH) Test Product Image Figure 2. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Anti-Mullerian Hormone (AMH) Test Market Share by Type: 2025 VS 2032 Figure 4. Chemiluminescence Immunoassay Image Figure 5. ELISA Image Figure 6. Magnetic Particle Chemiluminescence Image Figure 7. Flow Cytometry Fluorescence Luminescence Image Figure 8. Other Image Figure 9. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Anti-Mullerian Hormone (AMH) Test Market Share by Application: 2025 VS 2032 Figure 11. Assisted Reproduction Image Figure 12. Polycystic Ovary Syndrome Image Figure 13. Ovarian Cancer Image Figure 14. Other Image Figure 15. Global Anti-Mullerian Hormone (AMH) Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 17. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Anti-Mullerian Hormone (AMH) Test Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Anti-Mullerian Hormone (AMH) Test Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Type (2021-2032) Figure 24. Global Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Application (2021-2032) Figure 26. North America Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 27. North America Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032) Figure 28. North America Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032) Figure 29. North America Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032) Figure 30. United States Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 31. Canada Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 33. Europe Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 34. Europe Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032) Figure 35. Europe Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032) Figure 36. Europe Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032) Figure 37. Germany Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 38. France Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 40. Italy Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 41. Russia Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 43. China Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 44. China Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032) Figure 45. China Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032) Figure 46. Asia Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 47. Asia Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032) Figure 48. Asia Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032) Figure 49. Asia Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032) Figure 50. Japan Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 54. India Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 55. Australia Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032) Figure 60. Brazil Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 65. UAE Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 67. Chile Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Chemiluminescence Immunoassay
  • ELISA
  • Magnetic Particle Chemiluminescence
  • Flow Cytometry Fluorescence Luminescence
  • Other
Applications
  • Assisted Reproduction
  • Polycystic Ovary Syndrome
  • Ovarian Cancer
  • Other
Companies covered
  • Roche
  • Beckman Coulter
  • BioMérieux
  • Monash IVF
  • Bumrungrad International Hospital
  • CTK Biotech
  • Biotime
  • Boditech Med
  • CREATE Fertility
  • Repromed Fertility Specialists
  • Quest Health
  • Clinpath Pathology
  • Shenzhen YHLO Biotech
  • Guangzhou Kangrun Biotechnology
  • Guangzhou Wondfo Biotech
  • Beijing Savant Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Chemiluminescence Immunoassay
  5. 1.2.3 ELISA
  6. 1.2.4 Magnetic Particle Chemiluminescence
  7. 1.2.5 Flow Cytometry Fluorescence Luminescence
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Assisted Reproduction
  12. 1.3.3 Polycystic Ovary Syndrome
  13. 1.3.4 Ovarian Cancer
  14. 1.3.5 Other
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Anti-Mullerian Hormone (AMH) Test Growth Trends by Region
  17. 1.5.1 Global Anti-Mullerian Hormone (AMH) Test Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Anti-Mullerian Hormone (AMH) Test Market Size by Region (2021-2026)
  19. 1.5.3 Anti-Mullerian Hormone (AMH) Test Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Anti-Mullerian Hormone (AMH) Test Market Dynamics
  1. 2.1 Anti-Mullerian Hormone (AMH) Test Industry Trends
  2. 2.2 Anti-Mullerian Hormone (AMH) Test Industry Drivers
  3. 2.3 Anti-Mullerian Hormone (AMH) Test Industry Opportunities and Challenges
  4. 2.4 Anti-Mullerian Hormone (AMH) Test Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Anti-Mullerian Hormone (AMH) Test Revenue by Company (2021-2026)
  2. 3.2 Global Anti-Mullerian Hormone (AMH) Test Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Anti-Mullerian Hormone (AMH) Test Key Company Head office and Area Served
  4. 3.4 Global Anti-Mullerian Hormone (AMH) Test Company, Product Type & Application
  5. 3.5 Global Anti-Mullerian Hormone (AMH) Test Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Anti-Mullerian Hormone (AMH) Test Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Anti-Mullerian Hormone (AMH) Test Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Anti-Mullerian Hormone (AMH) Test Tier 1, Tier 2, and Tier 3
4 Anti-Mullerian Hormone (AMH) Test Market by Type
  1. 4.1 Global Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2032)
  3. 4.3 Global Anti-Mullerian Hormone (AMH) Test Market Size Share by Type (2021-2032)
5 Anti-Mullerian Hormone (AMH) Test Market by Application
  1. 5.1 Global Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2032)
  3. 5.3 Global Anti-Mullerian Hormone (AMH) Test Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche Anti-Mullerian Hormone (AMH) Test Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Beckman Coulter
  8. 6.2.1 Beckman Coulter Company Information
  9. 6.2.2 Beckman Coulter Business Overview
  10. 6.2.3 Beckman Coulter Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Beckman Coulter Anti-Mullerian Hormone (AMH) Test Product Portfolio
  12. 6.2.5 Beckman Coulter Recent Developments
  13. 6.3 BioMérieux
  14. 6.3.1 BioMérieux Company Information
  15. 6.3.2 BioMérieux Business Overview
  16. 6.3.3 BioMérieux Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 BioMérieux Anti-Mullerian Hormone (AMH) Test Product Portfolio
  18. 6.3.5 BioMérieux Recent Developments
  19. 6.4 Monash IVF
  20. 6.4.1 Monash IVF Company Information
  21. 6.4.2 Monash IVF Business Overview
  22. 6.4.3 Monash IVF Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Monash IVF Anti-Mullerian Hormone (AMH) Test Product Portfolio
  24. 6.4.5 Monash IVF Recent Developments
  25. 6.5 Bumrungrad International Hospital
  26. 6.5.1 Bumrungrad International Hospital Company Information
  27. 6.5.2 Bumrungrad International Hospital Business Overview
  28. 6.5.3 Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Product Portfolio
  30. 6.5.5 Bumrungrad International Hospital Recent Developments
  31. 6.6 CTK Biotech
  32. 6.6.1 CTK Biotech Company Information
  33. 6.6.2 CTK Biotech Business Overview
  34. 6.6.3 CTK Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 CTK Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  36. 6.6.5 CTK Biotech Recent Developments
  37. 6.7 Biotime
  38. 6.7.1 Biotime Company Information
  39. 6.7.2 Biotime Business Overview
  40. 6.7.3 Biotime Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Biotime Anti-Mullerian Hormone (AMH) Test Product Portfolio
  42. 6.7.5 Biotime Recent Developments
  43. 6.8 Boditech Med
  44. 6.8.1 Boditech Med Company Information
  45. 6.8.2 Boditech Med Business Overview
  46. 6.8.3 Boditech Med Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Boditech Med Anti-Mullerian Hormone (AMH) Test Product Portfolio
  48. 6.8.5 Boditech Med Recent Developments
  49. 6.9 CREATE Fertility
  50. 6.9.1 CREATE Fertility Company Information
  51. 6.9.2 CREATE Fertility Business Overview
  52. 6.9.3 CREATE Fertility Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 CREATE Fertility Anti-Mullerian Hormone (AMH) Test Product Portfolio
  54. 6.9.5 CREATE Fertility Recent Developments
  55. 6.10 Repromed Fertility Specialists
  56. 6.10.1 Repromed Fertility Specialists Company Information
  57. 6.10.2 Repromed Fertility Specialists Business Overview
  58. 6.10.3 Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Product Portfolio
  60. 6.10.5 Repromed Fertility Specialists Recent Developments
  61. 6.11 Quest Health
  62. 6.11.1 Quest Health Company Information
  63. 6.11.2 Quest Health Business Overview
  64. 6.11.3 Quest Health Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Quest Health Anti-Mullerian Hormone (AMH) Test Product Portfolio
  66. 6.11.5 Quest Health Recent Developments
  67. 6.12 Clinpath Pathology
  68. 6.12.1 Clinpath Pathology Company Information
  69. 6.12.2 Clinpath Pathology Business Overview
  70. 6.12.3 Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  72. 6.12.5 Clinpath Pathology Recent Developments
  73. 6.13 Shenzhen YHLO Biotech
  74. 6.13.1 Shenzhen YHLO Biotech Company Information
  75. 6.13.2 Shenzhen YHLO Biotech Business Overview
  76. 6.13.3 Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  78. 6.13.5 Shenzhen YHLO Biotech Recent Developments
  79. 6.14 Guangzhou Kangrun Biotechnology
  80. 6.14.1 Guangzhou Kangrun Biotechnology Company Information
  81. 6.14.2 Guangzhou Kangrun Biotechnology Business Overview
  82. 6.14.3 Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  84. 6.14.5 Guangzhou Kangrun Biotechnology Recent Developments
  85. 6.15 Guangzhou Wondfo Biotech
  86. 6.15.1 Guangzhou Wondfo Biotech Company Information
  87. 6.15.2 Guangzhou Wondfo Biotech Business Overview
  88. 6.15.3 Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  90. 6.15.5 Guangzhou Wondfo Biotech Recent Developments
  91. 6.16 Beijing Savant Biotechnology
  92. 6.16.1 Beijing Savant Biotechnology Company Information
  93. 6.16.2 Beijing Savant Biotechnology Business Overview
  94. 6.16.3 Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  96. 6.16.5 Beijing Savant Biotechnology Recent Developments
7 North America
  1. 7.1 North America Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
  2. 7.2 North America Anti-Mullerian Hormone (AMH) Test Market Size by Type
  3. 7.2.1 North America Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026)
  4. 7.2.2 North America Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032)
  5. 7.2.3 North America Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032)
  6. 7.3 North America Anti-Mullerian Hormone (AMH) Test Market Size by Application
  7. 7.3.1 North America Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026)
  8. 7.3.2 North America Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032)
  9. 7.3.3 North America Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032)
  10. 7.4 North America Anti-Mullerian Hormone (AMH) Test Market Size by Country
  11. 7.4.1 North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
  13. 7.4.3 North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032)
  14. 7.4.4 North America Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
  2. 8.2 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Type
  3. 8.2.1 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026)
  4. 8.2.2 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032)
  5. 8.2.3 Europe Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032)
  6. 8.3 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Application
  7. 8.3.1 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026)
  8. 8.3.2 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032)
  9. 8.3.3 Europe Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032)
  10. 8.4 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country
  11. 8.4.1 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
  13. 8.4.3 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032)
  14. 8.4.4 Europe Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
  2. 9.2 China Anti-Mullerian Hormone (AMH) Test Market Size by Type
  3. 9.2.1 China Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026)
  4. 9.2.2 China Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032)
  5. 9.2.3 China Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032)
  6. 9.3 China Anti-Mullerian Hormone (AMH) Test Market Size by Application
  7. 9.3.1 China Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026)
  8. 9.3.2 China Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032)
  9. 9.3.3 China Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
  2. 10.2 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Type
  3. 10.2.1 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026)
  4. 10.2.2 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032)
  5. 10.2.3 Asia Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032)
  6. 10.3 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Application
  7. 10.3.1 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026)
  8. 10.3.2 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032)
  9. 10.3.3 Asia Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032)
  10. 10.4 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Country
  11. 10.4.1 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
  13. 10.4.3 Asia Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032)
  14. 10.4.4 Asia Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research